🇺🇸 FDA

Intelligence · Patents

Patents expiring in 2032

Annual patent cliff calendar for 2032 — US pharmaceutical patents by expiration date.

Patents
1,123

Quick answer

1,123 indexed pharmaceutical patents have expiration dates in 2032. Browse by soonest expiry with links to assignee companies and related drugs.

  1. US 8168626

    Benzodiazepine compositions for treating epidermal hyperplasia and related disorders

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue May 01 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 8168202

    Hexavalent bovine rotavirus reassortant composition designed for use in developing countries

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue May 01 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 8168222

    Amphiphilic polymer-protein conjugates and methods of use thereof

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Tue May 01 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 8168200

    Vaccine against african horse sickness virus

    The Regents of the University of California · Granted Tue May 01 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 8168591

    Compositions and methods related to anti-FGF agents

    The Regents of the University of California · Granted Tue May 01 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 8168775

    Compositions and methods for inhibiting expression of transthyretin

    Alnylam Pharmaceuticals, Inc. · Granted Tue May 01 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 8168776

    Method for making a 21 nucleotide double stranded RNA chemically linked at one end

    Alnylam Pharmaceuticals, Inc. · Granted Tue May 01 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 8168798

    Caspase inhibitor prodrugs

    Vertex Pharmaceuticals Incorporated · Granted Tue May 01 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 8168754

    Modified vitamin K-dependent polypeptides

    Regents of the University of Minnesota · Granted Tue May 01 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 8168585

    Purification of peptides from colostrum

    Regen Therapeutics PLC · Granted Tue May 01 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 8173133

    Acyl pseudodipeptides which carry a functionalized auxiliary arm

    OM PHARMA · Granted Tue May 08 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 03 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 8173392

    In vivo incorporation of unnatural amino acids

    The Regents of the University of California · Granted Tue May 08 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 03 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 8173123

    Methods of treating colitis involving IL-13 and NK-T cells

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue May 08 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 03 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 8173628

    Steroidal antiestrogens and antiandrogens and uses thereof

    Northwestern University · Granted Tue May 08 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 03 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 8173115

    Particle compositions with a pre-selected cell internalization mode

    The Board of Regents of the University of Texas System · Granted Tue May 08 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 03 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 8173134

    ECD carboxy-terminal deletion FGFR4 fusion proteins and methods of producing them

    Five Prime Therapeutics, Inc. · Granted Tue May 08 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 03 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 8173135

    Methods for preparing complex multivalent immunogenic conjugates

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue May 08 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 03 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 8173158

    Methods of treating gastrointestinal disorders independent of the intake of food

    Takeda Pharmaceuticals U.S.A., Inc. · Granted Tue May 08 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 03 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 8173673

    Biofilm-inhibiting effect and anti-infective activity of N,C-linked aryl isoquinolines and the use thereof

    Julius-Maximilians-Universitat Wurzburg · Granted Tue May 08 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 03 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 8173360

    Cell death inhibitor

    Takeda Pharmaceutical Company Limited · Granted Tue May 08 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 03 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 8173602

    Detecting CYP24 expression level as a marker for predisposition to cancer

    The Regents of the University of California · Granted Tue May 08 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 03 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 8173666

    Oligomer-opioid agonist conjugates

    Nektar Therapeutics · Granted Tue May 08 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 03 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 8173362

    Cytomegalovirus surface protein complex for use in vaccines and as a drug target

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Tue May 08 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 03 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 8173364

    Methods and composition for the production of orthogonal tRNA-aminoacyl tRNA synthetase pairs

    The Regents of the University of California · Granted Tue May 08 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 03 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 8173645

    Glucokinase activators

    Takeda San Diego, Inc. · Granted Tue May 08 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 03 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 8173615

    TRPM-2 antisense therapy

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue May 08 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 03 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 8173663

    Dipeptidyl peptidase inhibitors

    Takeda Pharmaceutical Company Limited · Granted Tue May 08 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 03 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 8173664

    Modified pyrimidine glucocorticoid receptor modulators

    Corcept Therapeutics Incorporated · Granted Tue May 08 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 03 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 8173815

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Tue May 08 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 03 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 8173635

    Kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Tue May 08 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 03 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 8173424

    Internalizing ErbB2 antibodies

    The Regents of the University of California · Granted Tue May 08 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 03 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 8173139

    High energy electron beam irradiation for the production of immunomodulators in poultry

    The United States of America, as represented by the Secretary of Agriculture · Granted Tue May 08 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 03 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 8173120

    Method of preventing reduced feed intake in animals and treatment of disease conditions

    Precision Nutrition Pty Ltd · Granted Tue May 08 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 03 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 8178298

    Patched polypeptides and uses related thereto

    The Regents of the University of California · Granted Tue May 15 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 10 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 8178114

    Patch device for a fragrance and method of using the patch device

    Sentiv ApS · Granted Tue May 15 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 10 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 8178076

    Diagnosis and assessment of skeletal related disease using calcium 41

    The Regents of the University of California · Granted Tue May 15 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 10 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 8178109

    Compositions and methods of use for MGD-CSF in disease treatment

    Five Prime Therapeutics, Inc. · Granted Tue May 15 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 10 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 8178534

    cMET inhibitors

    Takeda Pharmaceutical Company Limited · Granted Tue May 15 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 10 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 8178537

    Solid state forms of varenicline salts and processes for preparation thereof

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue May 15 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 10 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 8178543

    Bi- and tricyclic fused pyrimidines as tyrosine kinase inhibitors

    Takeda Pharmaceutical Company Limited · Granted Tue May 15 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 10 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 8178679

    Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the β2 adrenergic receptors

    Almirall, S.A. · Granted Tue May 15 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 10 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 8178513

    Heterocyclic aspartyl protease inhibitors

    Pharmacopeia Drug Discovery, Inc. · Granted Tue May 15 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 10 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 8178508

    Methods of stimulating an immune response against prostate specific antigen

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue May 15 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 10 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 8178127

    Stable laquinimod preparations

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue May 15 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 10 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 8178531

    Antiviral agents

    Enanta Pharmaceuticals, Inc. · Granted Tue May 15 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 10 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 8178671

    Methods of treating or preventing autoimmune diseases with 2, 4-pyrimidinediamine compounds

    Rigel Pharmaceuticals, Inc. · Granted Tue May 15 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 10 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 8178555

    Apoptosis signal-regulating kinase 1 inhibitors

    Takeda Pharmaceutical Company Limited · Granted Tue May 15 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 10 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 8182836

    Abuse-resistant oral dosage forms and method of use thereof

    Elite Laboratories, Inc. · Granted Tue May 22 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 17 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many pharma patents expire in 2032?

1,123 published patents in our USPTO index have expiration dates falling in calendar year 2032.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.